How fecal microbiota transplantation could transform cancer immunotherapy Emerging clinical trials suggest that the gut microbiome plays a decisive role in how patients respond to immunotherapy.

https://www.drugdiscoverynews.com/how-fecal-microbiota-transplantation-could-transform-cancer-immunotherapy-17017?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz--4kQ_C3KxJHBwe_rqWxQYVu8cqK5i8lORT7KPHNKa0aU1vwQQz1YFvl93OyUTJNW0xbUE10WDIkFXmVmluSfMRX6H4kw&_hsmi=405045738&utm_content=405045738&utm_source=hs_email Over the past decade, scientists have learned that cancer is not driven by tumor cells alone. Disruptions in the gut microbiome have been linked to cancer development and progression through effects on genomic stability, immune evasion, and the tumor microenvironment.